pharma · Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma · metastatic or unresectable, recurrent HNSCC
Createrna Science and
Wuhan Createrna Science and Technology Co., Ltd
News and analysis for Createrna Science and on NovaPharmaNews — regulatory, clinical, and market coverage.
shanghai, CN, London HQ
26 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- shanghai, CN, London
- Employees
- 26
- Programs
- 51
- Drugs
- 87
- Patents
- 0
News & analysis
NovaPharmaNews articles mentioning Createrna Science and — regulatory, clinical, and market coverage.
News and analysis for Createrna Science and on NovaPharmaNews — regulatory, clinical, and market coverage.